Cohen Klingenstein’s Celgene Corp CELG Stock Holding History

Cohen Klingenstein’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,116	Closed	-$4.98M	–	241
2019 Q3	$4.98M	Buy	50,116 +4,400	+10%	+$418K	0.31%	73
2019 Q2	$4.23M	Sell	45,716 -4,539	-9%	-$431K	0.3%	75
2019 Q1	$4.74M	Buy	50,255 +37,015	+280%	+$3.24M	0.33%	63
2018 Q4	$849K	Hold	13,240	–	–	0.13%	97
2018 Q3	$1.19M	Hold	13,240	–	–	0.15%	94
2018 Q2	$1.05M	Hold	13,240	–	–	0.14%	95
2018 Q1	$1.18M	Hold	13,240	–	–	0.17%	91
2017 Q4	$1.38M	Hold	13,240	–	–	0.2%	84
2017 Q3	$1.93M	Hold	13,240	–	–	0.29%	68
2017 Q2	$1.72M	Hold	13,240	–	–	0.27%	70
2017 Q1	$1.65M	Hold	13,240	–	–	0.26%	70
2016 Q4	$1.53M	Hold	13,240	–	–	0.26%	71
2016 Q3	$1.38M	Hold	13,240	–	–	0.24%	70
2016 Q2	$1.31M	Hold	13,240	–	–	0.24%	72
2016 Q1	$1.32M	Sell	13,240 -310	-2%	-$31.9K	0.25%	69
2015 Q4	$1.62M	Sell	13,550 -1,850	-12%	-$214K	0.3%	62
2015 Q3	$1.67M	Hold	15,400	–	–	0.33%	52
2015 Q2	$1.78M	Sell	15,400 -310	-2%	-$35.4K	0.32%	54
2015 Q1	$1.81M	Sell	15,710 -230	-1%	-$27.5K	0.33%	52
2014 Q4	$1.78M	Hold	15,940	–	–	0.33%	50
2014 Q3	$1.51M	Hold	15,940	–	–	0.27%	60
2014 Q2	$1.37M	Hold	15,940	–	–	0.26%	60
2014 Q1	$1.11M	Hold	15,940	–	–	0.22%	74
2013 Q4	$1.35M	Hold	15,940	–	–	0.27%	60
2013 Q3	$1.23M	Hold	15,940	–	–	0.27%	61
2013 Q2	$932K	Buy	+15,940	New	+$959K	0.22%	79

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Cohen Klingenstein's CELG Position: Q4 2019 in Review

Cohen Klingenstein sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 50,116 shares — an estimated $4.98M sold.

Cohen Klingenstein first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.98M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Cohen Klingenstein reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Cohen Klingenstein sold 50,116 Celgene Corp shares in Q4 2019, an estimated $4.98M.
Cohen Klingenstein first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
Cohen Klingenstein's Celgene Corp position peaked at $4.98M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cohen Klingenstein's 13F filing for Q4 2019, filed 15 Jan 2020.